CAS: 1415925-18-6
Marca | Datos del producto | Pureza | Rango de precios | Entrega estimada |
---|---|---|---|---|
GSK2795039 REF: TM-T15433CAS: 1415925-18-6 | 95.8% - 98.68% | 72,00 €~874,00 € | Vie 13 Dic 24 | |
GSK2795039 REF: 3D-QGC92518CAS: 1415925-18-6 | Min. 95% | A consultar | Vie 24 Ene 25 | |
N-(1-Isopropyl-3-(1-methylindolin-6-yl)-1H-pyrrolo[2,3-b]pyridin-4-yl)-1-methyl-1H-pyrazole-3-sulfonamide REF: IN-DA009CN0CAS: 1415925-18-6 | 97% | - - - | Producto descatalogado |
GSK2795039
CAS:1415925-18-6
GSK2795039 reduces ROS, NADPH use, apoptosis, and inhibits NOX2 (pIC50: 6).
Fórmula:
C23H26N6O2S
Pureza:
95.8% - 98.68%
Forma y color:
Solid
Peso molecular:
450.56
Ref: TM-T15433
1mg | 72,00 € | ||
2mg | 95,00 € | ||
5mg | 158,00 € | ||
10mg | 239,00 € | ||
25mg | 420,00 € | ||
50mg | 613,00 € | ||
100mg | 874,00 € | ||
1mL*10mM (DMSO) | 168,00 € |
Entrega estimada en Estados Unidos, el Viernes 13 de Diciembre de 2024
GSK2795039
CAS:1415925-18-6
GSK2795039 is a molecule that may be a potential therapeutic for hypoxic tumours. GSK2795039 inhibits …
Fórmula:
C23H26N6O2S
Pureza:
Min. 95%
Peso molecular:
450.56 g/mol
Ref: 3D-QGC92518
5mg | A consultar | ||
10mg | A consultar | ||
25mg | A consultar | ||
50mg | A consultar |
Entrega estimada en Estados Unidos, el Viernes 24 de Enero de 2025
N-(1-Isopropyl-3-(1-methylindolin-6-yl)-1H-pyrrolo[2,3-b]pyridin-4-yl)-1-methyl-1H-pyrazole-3-sulfonamide
CAS:1415925-18-6
Fórmula:
C23H26N6O2S
Pureza:
97%
Forma y color:
Solid
Peso molecular:
450.5565
Ref: IN-DA009CN0
1mg | Descatalogado | Solicitar información | |
10mg | Descatalogado | Solicitar información | |
25mg | Descatalogado | Solicitar información | |
50mg | Descatalogado | Solicitar información | |
100mg | Descatalogado | Solicitar información | |
250mg | Descatalogado | Solicitar información |